Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats

Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats

Item
http://www.wikidata.org/entity/Q28578958
Estrogen, aging and the cardiovascular systemLong- but not short-term estradiol treatment induces renal damage in midlife ovariectomized Long-Evans rats.The Importance of Biological Sex and Estrogen in Rodent Models of Cardiovascular Health and DiseaseVentilation and phrenic output following high cervical spinal hemisection in male vs. female rats.Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female ratsEffects of short-term administration of estradiol on reperfusion arrhythmias in rats of different ages.The chronic blockade of angiotensin I-converting enzyme eliminates the sex differences of serum cytokine levels of spontaneously hypertensive rats.Ovariectomy does not affect the cardiac sympathovagal balance of female SHR but estradiol does.Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats.
P2860

Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats

Item
http://www.wikidata.org/entity/Q28578958
description
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Oktober 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/10/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/10/01)
@nl
наукова стаття, опублікована в жовтні 2006
@uk
مقالة علمية (نشرت في أكتوبر 2006)
@ar
name
Aging reduces the efficacy of ...... pontaneously hypertensive rats
@ast
Aging reduces the efficacy of ...... pontaneously hypertensive rats
@en
Aging reduces the efficacy of ...... pontaneously hypertensive rats
@nl
type
label
Aging reduces the efficacy of ...... pontaneously hypertensive rats
@ast
Aging reduces the efficacy of ...... pontaneously hypertensive rats
@en
Aging reduces the efficacy of ...... pontaneously hypertensive rats
@nl
prefLabel
Aging reduces the efficacy of ...... pontaneously hypertensive rats
@ast
Aging reduces the efficacy of ...... pontaneously hypertensive rats
@en
Aging reduces the efficacy of ...... pontaneously hypertensive rats
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Aging reduces the efficacy of ...... pontaneously hypertensive rats
@en
P2093
P304
P31
P356
10.1161/01.HYP.0000240053.48517.C7
P407
P433
P478
P577
P698